Dr. Jackie Bosch PhD

Publications are listed in chronological order by descending date. Link takes user to pubMed for publication details.

• Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.

  Source: N Engl J Med

• Does Lowering Blood Pressure With Antihypertensive Therapy Preserve Independence in Activities of Daily Living? A Systematic Review.

  Source: Am J Hypertens

• The mini-mental state examination, clinical factors, and motor vehicle crash risk.

  Source: J Am Geriatr Soc

• Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.

  Source: Lancet Diabetes Endocrinol

• Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial.

  Source: Diabetologia

• Association of handgrip strength to cardiovascular mortality in pre-diabetic and diabetic patients: a subanalysis of the ORIGIN trial.

  Source: Int J Cardiol

• Aliskiren alone or with other antihypertensives in the elderly with borderline and stage 1 hypertension: the APOLLO trial.

  Source: Eur Heart J

• The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia.

  Source: Diabetes Care

• Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes.

  Source: Anesthesiology

• Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges.

  Source: Eur Heart J

• Randomized clinical trials–removing unnecessary obstacles.

  Source: N Engl J Med

• Setting the record straight on TIDE: a lost opportunity for patients with diabetes.

  Source: Diabetologia

• Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: the EpiDREAM genetic study.

  Source: Diabetes Care

• Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE).

  Source: Diabetes Care

• Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.

  Source: Am Heart J

• Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.

  Source: JAMA

• Basal insulin and cardiovascular and other outcomes in dysglycemia.

  Source: N Engl J Med

• n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

  Source: N Engl J Med

• Cognitive impairment and risk of cardiovascular events and mortality.

  Source: Eur Heart J

• Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies.

  Source: CMAJ

• The fluid study protocol: a randomized controlled study on the effects of bioimpedance analysis and vitamin D on left ventricular mass in peritoneal dialysis patients.

  Source: Perit Dial Int

• The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.

  Source: Circulation

• Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).

  Source: J Am Coll Cardiol

• Lipid lowering for primary prevention.

  Source: Lancet

• Specific barriers to the conduct of randomized trials.

  Source: Clin Trials

• Sensible guidelines for the conduct of large randomized trials.

  Source: Clin Trials

• Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

  Source: Am Heart J

• Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients.

  Source: Eur Heart J

• Independent design and conduct of clinical trials.

  Source: Clin Trials

• Effect of ramipril on the incidence of diabetes.

  Source: N Engl J Med

• Home and community occupational therapy for children and youth: a before and after study.

  Source: Can J Occup Ther

• Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.

  Source: Circulation

• Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

  Source: JAMA

• Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.

  Source: Am Heart J

• Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.

  Source: Circulation

• Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.

  Source: J Am Coll Cardiol

• Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.

  Source: Kidney Int

• Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients.

  Source: Eur J Cardiovasc Prev Rehabil

• Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.

  Source: Circulation

• Preventing stroke with ramipril–authors’ reply.

  Source: BMJ

• Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

  Source: Diabetes Care

• Effect of long-term therapy with ramipril in high-risk women.

  Source: J Am Coll Cardiol

• Use of ramipril in preventing stroke: double blind randomised trial.

  Source: BMJ